MedPath

Clinic-based Intervention to Promote Cervical Cancer Prevention Behaviors

Not Applicable
Completed
Conditions
Cervical Cancer
Interventions
Behavioral: Step Up to Prevention
Behavioral: Offered HPV vaccine only
Registration Number
NCT02046265
Lead Sponsor
University of Pennsylvania
Brief Summary

The project is a clinical behavioral research project based at University of Pennsylvania. The goal of this research is to design a brief clinic-based, Nurse Practitioner-guided, and theory-based health promotion intervention to enhance cervical cancer prevention among young women ages 18-26 living in economically disadvantaged urban communities. The investigators will evaluate the intervention for feasibility, acceptability and preliminary efficacy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • Age 18-26 years
  • Not yet received the HPV vaccine
  • Speak, read, and understand 5th grade level of English;
  • Had vaginal sex with a male partner in the past 2 months.
Read More
Exclusion Criteria

• Currently pregnant and/or plan to be pregnant in next 6 months

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Step Up to Prevention:beliefStep Up to PreventionParticipant receives a one-on-one tailored educational session with a trained study team member and participant is offered the HPV vaccine only by their nurse practitioner in clinic.
Step up to PreventionStep Up to PreventionParticipant receives both the knowledge session and the tailored belief sessions and the participant is offered the HPV vaccine only by their nurse practitioner in clinic. This combined intervention is call Step Up to Prevention.
Offered HPV vaccine onlyOffered HPV vaccine onlyParticipant is offered the HPV vaccine only by their nurse practitioner in clinic.
Step Up to Prevention: knowledgeStep Up to PreventionParticipant receives an individual computer-delivered information session and participant is offered the HPV vaccine only by their nurse practitioner in clinic.
Primary Outcome Measures
NameTimeMethod
Human Papilloma Virus (HPV) Vaccine #1 AcceptanceFor each participant, at end of first study visit. Will assess until all subjects enrolled in study.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital of the University of Pennsylvania, Outpatient Ob/GYN clinic

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath